Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

305 results found

2025 ∙ Akther, A. Laurie, C. Elton-Marshall, T. Ly, V. Sulis, G.

Healthcare workers' current practices, knowledge/awareness, barriers, and attitudes/perceptions related to pneumococcal vaccination of older adults: A mixed-methods systematic review

  • All age groups
  • Healthcare workers
  • Pneumococcal disease
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Rahimi, H. K. Jasim, A. A. Rezahosseini, O. Harboe, Z. B.

Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Influenza
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Niyati, R. Rezahosseini, O. Ekenberg, C. Larsen, C. S. Harboe, Z. B.

Immunogenicity and Safety of Pneumococcal Vaccines Co-Administered with Common Travel Vaccines in Adults: A Systematic Review +

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Ngamprasertchai, T. Ruenroengbun, N. Kajeekul, R.

Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Pacheco-Haro, M. D. de Arenas-Arroyo, S. N. Diaz-Goni, V. Velasco-Lucio, E. J. Castellares-Gonzalez, C. I. Reynolds-Cortez, V. Simeon-Prieto, A. Ignateva, E. Martinez-Vizcaino, V.

Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine Versus a 13-Valent Vaccine in Infants: A Systematic Review and Meta-Analysis

  • Newborn
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
High
2025 ∙ Ul Haq, M. Z. Irfan, H. Shah, M. S. U. Sumbal, A. Mughal, S. Ashraf, S. Basaria, A. A. A. Abdullah, Chacho, M. A. Ayalew, B. D.

Immunogenicity, safety and tolerability of 15-valent pneumococcal conjugate vaccine (V114) compared to 13-valent pneumococcal conjugate vaccine (PCV-13) in healthy infants: A systematic review and meta-analysis

  • Newborn
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Regmi, S. Pande, R. Wyatt, T. H. Niederhauser, V.

Impact of COVID-19 on Parental Barriers to Childhood Vaccination: A Systematic Review

  • Americas
  • United States of America
  • Newborn
  • Children
  • Adolescents
  • Parents/caregivers
  • COVID-19
  • Hepatitis B
  • Rotavirus
  • Diphtheria
  • Tetanus
  • Pertussis
  • Haemophilus influenzae type B
  • Pneumococcal disease
  • Poliomyelitis
  • Influenza
  • Measles
  • Mumps
  • Rubella
  • Varicella
  • Hepatitis A
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Amare, S. N. Yee, K. C. Leung, M. Naunton, M. Bushell, M.

Impact of pharmacist-led interventions on COVID-19, herpes zoster, influenza, pneumococcal, and respiratory syncytial virus vaccines uptake in people aged 60 years and older: Systematic review and meta-analysis

  • Adults
  • Older adults
  • Herpes zoster
  • Influenza
  • Pneumococcal disease
  • RSV (Respiratory syncytial virus)
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Waszkiewicz, M. Wnuk, K. Switalski, J. Augustynowicz, A.

Knowledge, attitudes, and beliefs of pharmacists regarding vaccinations against influenza and pneumococci - a systematic review

  • Healthcare workers
  • Influenza
  • Pneumococcal disease
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Baiocchi, C. Bhardwaj, M.

Parental vaccine refusal, non-vaccinated children, and outbreaks of Vaccine-Preventable Diseases (VPDs) in Europe: a systematic review of aetiology and risk

  • Europe
  • Newborn
  • Children
  • Adolescents
  • Parents/caregivers
  • Diphtheria
  • Haemophilus influenzae type B
  • Hepatitis B
  • Human papillomavirus (HPV)
  • Measles
  • Rubella
  • Mumps
  • Pertussis
  • Pneumococcal disease
  • Poliomyelitis
  • Tetanus
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...